論文・総説 - 横田　隆徳

1. Matsubayashi T, Yokoyama K, Tateishi U, Yokota T, Sanjo N. Specifically Decreased Thalamic Blood Flow Following COVID-19 Infection. Clinical nuclear medicine. 2024.11; 49 (11): 1041-1043. ( PubMed, DOI )

2. Yokote H, Miyazaki Y, Fujimori J, Nishida Y, Toru S, Niino M, Nakashima I, Miura Y, Yokota T. Slowly expanding lesions are associated with disease activity and gray matter loss in relapse-onset multiple sclerosis. Journal of neuroimaging : official journal of the American Society of Neuroimaging. 2024.10; ( PubMed, DOI )

3. Hasegawa J, Nagata T, Ihara K, Tanihata J, Ebihara S, Yoshida-Tanaka K, Yanagidaira M, Ohara M, Sasaki A, Nakayama M, Yamamoto S, Ishii T, Iwata-Hara R, Naito M, Miyata K, Sakaue F, Yokota T. Heteroduplex oligonucleotide technology boosts oligonucleotide splice switching activity of morpholino oligomers in a Duchenne muscular dystrophy mouse model. Nature communications. 2024.09; 15 (1): 7530. ( PubMed, DOI )

4. Ohara M, Nagata T, Hara RI, Yoshida-Tanaka K, Toide N, Takagi K, Sato K, Takenaka T, Nakakariya M, Miyata K, Maeda Y, Toh K, Wada T, Yokota T. DNA/RNA heteroduplex technology with cationic oligopeptide reduces class-related adverse effects of nucleic acid drugs. Molecular therapy. Nucleic acids. 2024.09; 35 (3): 102289. ( PubMed, DOI )

5. Takahashi S, Ono D, Shintaku H, Oyama J, Nishida Y, Ishikawa K, Yokota T. Cryptogenic New-onset Refractory Status Epilepticus with Hyperintensity of T1-weighted Magnetic Resonance Imaging in the Bilateral Basal Ganglia: An Autopsy Report. Internal medicine (Tokyo, Japan). 2024.09; ( PubMed, DOI )

6. Hirata K, Matsuoka K, Tagai K, Endo H, Tatebe H, Ono M, Kokubo N, Kataoka Y, Oyama A, Shinotoh H, Takahata K, Obata T, Dehghani M, Near J, Kawamura K, Zhang MR, Shimada H, Shimizu H, Kakita A, Yokota T, Tokuda T, Higuchi M, Takado Y. In Vivo Assessment of Astrocyte Reactivity in Patients with Progressive Supranuclear Palsy. Annals of neurology. 2024.08; 96 (2): 247-261. ( PubMed, DOI )

7. Takahashi Sunao, Sanjo Nobuo, Koike Ryuji, Yokota Takanori. Eculizumab administration for myasthenia gravis also stabilizes thrombogenicity of catastrophic antiphospholipid syndrome Clinical and Experimental Neuroimmunology. 2024.08; 15 (3): 143-145. ( 医中誌 )

8. Ohara M, Hattori T, Chen Q, Shimano K, Hirata K, Matsui M, Yokota T. Is there a spinal tap responder in progressive supranuclear palsy? The first prospective study. Journal of neurology. 2024.07; 271 (7): 4473-4484. ( PubMed, DOI )

9. Ohara M, Hirata K, Matsubayashi T, Chen Q, Shimano K, Hanazawa R, Hirakawa A, Yokota T, Hattori T. Circular walking is useful for assessing the risk of falls in early progressive supranuclear palsy. Journal of neurology. 2024.07; ( PubMed, DOI )

10. Yokote H, Miyazaki Y, Fujimori J, Nishida Y, Toru S, Niino M, Nakashima I, Miura Y, Yokota T. Characterization of Japanese multiple sclerosis patients with progression independent of relapse activity: A 2-year multicenter cohort study. Journal of neuroimmunology. 2024.07; 394 578407. ( PubMed, DOI )

11. Sakurai K, Tokumaru AM, Yoshida M, Saito Y, Wakabayashi K, Komori T, Hasegawa M, Ikeuchi T, Hayashi Y, Shimohata T, Murayama S, Iwasaki Y, Uchihara T, Sakai M, Yabe I, Tanikawa S, Takigawa H, Adachi T, Hanajima R, Fujimura H, Hayashi K, Sugaya K, Hasegawa K, Sano T, Takao M, Yokota O, Miki T, Kobayashi M, Arai N, Ohkubo T, Yokota T, Mori K, Ito M, Ishida C, Idezuka J, Toyoshima Y, Kanazawa M, Aoki M, Hasegawa T, Watanabe H, Hashizume A, Niwa H, Yasui K, Ito K, Washimi Y, Kubota A, Toda T, Nakashima K, Aiba I, J-VAC study group. Conventional magnetic resonance imaging key features for distinguishing pathologically confirmed corticobasal degeneration from its mimics: a retrospective analysis of the J-VAC study. Neuroradiology. 2024.07; ( PubMed, DOI )

12. Matsubayashi T, Yoshioka K, Lei Mon SS, Katsuyama M, Jia C, Yamaguchi T, Hara RI, Nagata T, Nakagawa O, Obika S, Yokota T. Favorable efficacy and reduced acute neurotoxicity by antisense oligonucleotides with 2',4'-BNA/LNA with 9-(aminoethoxy)phenoxazine. Molecular therapy. Nucleic acids. 2024.06; 35 (2): 102161. ( PubMed, DOI )

13. Sano T, Nagata T, Ebihara S, Yoshida-Tanaka K, Nakamura A, Sasaki A, Shimozawa A, Mochizuki H, Uchihara T, Hasegawa M, Yokota T. Effects of local reduction of endogenous α-synuclein using antisense oligonucleotides on the fibril-induced propagation of pathology through the neural network in wild-type mice. Acta neuropathologica communications. 2024.05; 12 (1): 75. ( PubMed, DOI )

14. Ono D, Kawai H, Kuwahara H, Yokota T. Automated whole slide morphometry of sural nerve biopsy using machine learning. Neuropathology and applied neurobiology. 2024.04; 50 (2): e12967. ( PubMed, DOI )

15. Amano E, Sato W, Kimura Y, Kimura A, Lin Y, Okamoto T, Sato N, Yokota T, Yamamura T. CD11c(high) B Cell Expansion Is Associated With Severity and Brain Atrophy in Neuromyelitis Optica. Neurology(R) neuroimmunology & neuroinflammation. 2024.03; 11 (2): e200206. ( PubMed, DOI )

16. Sanjo N, Suzuki M, Yoshihama R, Toyoshima Y, Mizuta I, Fujita N, Usuda H, Uchiyama Y, Yasuda R, Yoshida T, Yamada M, Yokota T. Substitution of Glu to Lys at Codon 332 on the GFAP Gene Alone Is Causative for Adult-onset Alexander Disease. Internal medicine (Tokyo, Japan). 2024.01; 63 (2): 309-313. ( PubMed, DOI )

17. Okamoto T, Ishizuka T, Shimizu R, Asahina Y, Nakamura H, Shimizu Y, Nishida Y, Yokota T, Lin Y, Sato W, Yamamura T. Efficacy and Safety of the Natural Killer T Cell-Stimulatory Glycolipid OCH-NCNP1 for Patients With Relapsing Multiple Sclerosis: Protocol for a Randomized Placebo-Controlled Clinical Trial. JMIR research protocols. 2024.01; 13 e46709. ( PubMed, DOI )

18. Nishina K, Yoshioka K, Yokota T, Hara RI. Comparison of interaction between antimiR and microRNA versus HDO-antimiR and microRNA by molecular dynamics simulation. Nucleosides, nucleotides & nucleic acids. 2024.01; 1-16. ( PubMed, DOI )

19. Yum J, Aulia F, Kamiya K, Hori M, Qiao N, Kim BS, Naito M, Ogura S, Nagata T, Yokota T, Uchida S, Obika S, Kim HJ, Miyata K. Hydrophobicity Tuning of Cationic Polyaspartamide Derivatives for Enhanced Antisense Oligonucleotide Delivery. Bioconjugate chemistry. 2024.01; 35 (2): 125-131. ( PubMed, DOI )

20. Sanjo Nobuo, Suzuki Motohiro, Yoshihama Rei, Toyoshima Yasuko, Mizuta Ikuko, Fujita Nobuya, Usuda Hiroyuki, Uchiyama Yumiko, Yasuda Rei, Yoshida Tomokatsu, Yamada Masahito, Yokota Takanori. GFAP遺伝子コドン332におけるGluのLysへの置換は単独で成人発症アレキサンダー病の原因となる(Substitution of Glu to Lys at Codon 332 on the GFAP Gene Alone Is Causative for Adult-onset Alexander Disease) Internal Medicine. 2024.01; 63 (2): 309-313. ( 医中誌 )